Protalix BioTherapeutics, Inc. (PLX) stock
PLXNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 16/3048% below fair value
$2.96−0.17 (-5.43%)
Close on Nov 12, 2026Market cap $238.49MP/E 11.8Yield –
Protalix BioTherapeutics statistics
93 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 17, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.96
- 2.29
- P/OCF Ratio
- 13.58
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 2.56
- 2.60
- EV / EBIT
- 8.59
- 18.72
- EV / FCF
- 14.37
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- -4.17%
- 10.9%
- Float
- 77M
- 49M
- Shares Held by Insiders
- 3.82%
- 12.1%
- Shares Held by Institutions
- 17.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -0.81%
- -0.76%
- Short % of Float
- 4.49%
- 9.06%
- Short % of Shares Outstanding
- 4.32%
- 6.30%
- Days to Cover
- 6.18
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $3.19
- –
- 52-Week Low
- $1.65
- –
- 20-Day Moving Average
- $2.64
- –
- 50-Day Moving Average
- $2.68
- –
- 200-Day Moving Average
- $2.44
- –
- Average True Range (14)
- $0.15
- –
- Price Change (1 Week)
- 17.9%
- 1.51%
- Price Change (1 Month)
- 13.4%
- -2.37%
- Price Change (3 Months)
- 33.3%
- -21.1%
- Price Change (6 Months)
- 48.0%
- -22.8%
- Price Change (YTD)
- 64.4%
- -22.6%
- Price Change (1 Year)
- 39.0%
- -21.0%
- Price Change (3 Years)
- 119.3%
- -24.8%
- Price Change (5 Years)
- 159.6%
- -76.9%
- Price Change (10 Years)
- -38.3%
- -63.2%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 936,122
- –
- Average Volume (90 Days)
- 801,798
- –
- Relative Volume
- 3.12
- 0.80
- Relative Strength Index (14)
- 61.7
- 44.7
- Volatility (1 Year)
- 56.1%
- 80.2%
- Beta (5 Years)
- 0.86
- 1.07
MarginsIndustry
- Pretax Margin
- 30.5%
- -11.8%
- EBITDA Margin
- 29.8%
- -27.7%
- FCF Margin
- 17.8%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- 30.8%
- -51.3%
- Return on Assets (ROA)
- 20.5%
- -40.7%
- Return on Invested Capital (ROIC)
- 41.0%
- -32.9%
- Return on Capital Employed (ROCE)
- 28.6%
- -38.1%
Financial positionIndustry
- Current Ratio
- 3.27
- 3.31
- Quick Ratio
- 1.19
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- 37.0%
- 7.26%
- Net Income Growth (YoY)
- 281.0%
- -14.4%
- EPS Growth (YoY)
- 525.0%
- -11.7%
- Revenue Growth (3Y CAGR)
- 3.45%
- 2.25%
- Revenue Growth (5Y CAGR)
- -3.46%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.84
- 0.40
- Inventory Turnover
- 0.88
- 2.73
- Revenue Per Employee
- $374.75K
- $429.38K
- Profits Per Employee
- $90.93K
- -$683.67K
- Employee Count
- 226
- 75
- WACC
- 9.16%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- $25.85M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $22.04M
- $16.98M
- Net Cash Per Share
- $0.27
- $0.72
- Equity (Book Value)
- $80.55M
- $52.68M
- Book Value Per Share
- $1.00
- $1.50
- Tangible Book Value
- $80.55M
- $26.74M
- Working Capital
- $68.64M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$2.49M
- -$944.00K
- FCF Per Share
- $0.19
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 8.62%
- -21.0%
- FCF Yield
- 6.32%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $5.30M
- $74.00K
- Effective Tax Rate
- 20.5%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $2.37
- $19.34
- Graham Upside
- -19.9%
- -46.3%
- Altman Z-Score
- 5.91
- 0.26
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | PLX | S&P 500 | Difference | PLX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.5% | -2.7% | +9.2 pts | ||
| 3 months | +13.0% | -1.7% | +14.7 pts | ||
| Year to date | +64.4% | +11.9% | +52.5 pts | ||
| 1 year | +38.3% | +12.0% | +26.3 pts | ||
| 3 years | +120.9% | +78.2% | +42.7 pts | +30.2% | +21.2% |
| 5 years | +159.6% | +73.2% | +86.4 pts | +21.0% | +11.6% |
| 10 years | -38.3% | +309.6% | −348.0 pts | -4.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M PLX shares were sold short on Oct 30, 2026, down 0.8% from the previous report, or 4.49% of the shares available to trade. At recent volumes it would take 6.2 days to buy them back. Over the last 20 sessions, 44.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,480,033 | -0.8% | 563,101 | 6.2 |
| Oct 15, 2026 | 3,508,555 | +15.4% | 1,070,752 | 3.3 |
| Sep 30, 2026 | 3,040,042 | +5.6% | 709,069 | 4.3 |
| Sep 15, 2026 | 2,877,740 | -9.1% | 754,146 | 3.8 |
| Aug 31, 2026 | 3,165,145 | -11.5% | 666,406 | 4.8 |
| Aug 14, 2026 | 3,576,201 | -7.8% | 964,114 | 3.7 |
| Jul 31, 2026 | 3,878,764 | +4.4% | 520,066 | 7.5 |
| Jul 15, 2026 | 3,715,907 | +4.4% | 566,413 | 6.6 |
| Jun 30, 2026 | 3,558,923 | -9.0% | 851,438 | 4.2 |
| Jun 15, 2026 | 3,910,669 | -0.6% | 552,862 | 7.1 |
| May 29, 2026 | 3,935,161 | -5.9% | 798,578 | 4.9 |
| May 15, 2026 | 4,183,989 | -17.2% | 1,074,212 | 3.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?